featured
Caution Indicated With Concurrent Use of Cangrelor and Prasugrel in Patients Undergoing PCI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JACC: Cardiovascular Interventions
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study
JACC Cardiovasc Interv 2023 Oct 23;16(20)2528-2539, F Franchi, F Rollini, L Ortega-Paz, L Been, S Giordano, M Galli, G Ghanem, H Garabedian, T Al Saleh, E Uzunoglu, A Rivas, AM Pineda, S Suryadevara, D Soffer, MM Zenni, M Mahowald, B Reiter, B Jilma, DJ AngiolilloFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.